A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma

<div>Network meta-analysis of OS: (a) OS compared with Sun, (b) OS compared with Niv_Cab, and (c) OS compared with Niv_Ipi, and (d) stacking sort diagram of OS.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma 

Figure 4 | A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma 